Skip to main content
    V

    VivoSim Labs, Inc. (VIVS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.12
    -0.00 (-2.91%)

    Market Cap: $2.51M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    VivoSim Labs, Inc. (VIVS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    VivoSim Labs (VIVS) has a market cap of $2.51M. Its share count is up 531.31% from a year earlier. It holds $8.56M more cash than debt, 341.36% of its market cap.

    Total Valuation

    Market Cap$2.51M
    Latest price (Nov 17, 2026)$0.12

    Key Dates

    Last Earnings DateNov 12, 2026
    Fiscal Year EndMarch

    Share Statistics

    The share count rose 213.87% in the quarter ended Sep 30, 2026.

    Shares Outstanding16.45M
    Shares Change (YoY)+531.31%
    Shares Change (QoQ)+213.87%

    Valuation Ratios

    Sales and book value multiples are 14.6x and 0.3x. Its year-end P/S ranged from 4.3x to 81.1x from 2016 to 2025.

    P/S Ratio14.6x
    P/B Ratio0.3x

    Valuation history and multiples

    Price Statistics

    The stock is down 94.47% over 52 weeks and trades 36.84% below its 50-day average.

    Beta (1Y)1.84
    52-Week Change-94.47%
    1-Month Change-23.75%
    3-Month Change-56.69%
    6-Month Change-90.69%
    5-Year Change-99.79%
    10-Year Change-99.97%
    Total Return (1Y)-94.47%
    Total Return (3Y CAGR)-80.68%
    Total Return (5Y CAGR)-71.22%
    Max Drawdown (1Y)-95.89%
    Max Drawdown (3Y)-99.26%
    Sharpe Ratio (1Y)-2.57
    Correlation with SPY (1Y)0.22
    50-Day Average$0.19
    200-Day Average$0.96
    52-Week Range$0.12 to $3.40
    RSI (14 Days)34.0
    Average Volume (20 Days)1.22M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.50x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio3.50x
    Quick Ratio3.49x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -141.78% and return on assets is -103.47% over the last 12 months.

    Return on Equity (ROE)-141.78%
    Return on Assets (ROA)-103.47%
    ROIC (5Y Average)138.78%
    Inventory Turnover3.73x
    Receivables Turnover3.18x
    Cash Conversion Cycle-4917 days

    Scores

    VIVS has an Altman Z-Score of -52.71, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-52.71
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Balance Sheet

    Shareholder equity funds 72.98% of the $9.92M in total assets.

    Cash and Equivalents$8.56M
    Total Debt$0
    Net Cash$8.56M
    Net Cash Per Share$0.52
    Working Capital$6.71M
    Shareholder Equity$7.24M
    Book Value Per Share$0.44
    Total Assets$9.92M
    Total Liabilities$2.68M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Dividends and Yields

    VIVS does not pay a dividend.

    Buyback Yield32.76%
    Shareholder Yield32.76%

    Stock Splits

    The last split was a 1-for-12 reverse split on Mar 21, 2025.

    Last Split DateMar 21, 2025
    Split TypeReverse split
    Split Ratio1:12

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About VIVS

    What is VIVS's market cap?

    VivoSim Labs has a market cap of $2.51M.

    How many shares of VIVS are outstanding?

    VivoSim Labs has 16.45M shares outstanding. The count is up 531.31% from a year earlier.

    Does VIVS pay a dividend?

    No. VivoSim Labs does not pay a dividend.

    How much debt does VIVS have?

    VivoSim Labs has $0 of total debt and $8.56M of cash and equivalents, a net cash position of $8.56M.